Medical Toxicology

News

The latest in medical toxicology

Stay informed with the latest in medical toxicology. Explore news on research, poisoning outbreaks, global trends, and new treatments. Our news section covers everything from environmental toxins to regulatory updates, keeping you ahead in this field.

Substance Abuse and Overdose

Ole Miss Death Investigations Put Kratom in Spotlight—but Toxicology Results Are Still Pending

25 Sept 2026 · Updated 01 Oct 2026

Packaged kratom evidence beside forensic toxicology testing, illustrating two Ole Miss death investigations where product composition and causation remain unconfirmed.

Substance Abuse and Overdose

Fentanyl Purity Alone Does Not Explain the U.S. Overdose Decline, Study Finds

20 Sept 2026 · Updated 01 Oct 2026

Data graphic comparing fentanyl purity and overdose mortality across U.S. regions, illustrating why one national supply measure cannot explain the decline.

Latest Research and Studies

New Study Reopens Cefepime Mortality Safety Question

19 Sept 2026 · Updated 01 Oct 2026

Cefepime vial between published and FDA-provided trial evidence, showing 6.6% versus 6.2% mortality in the 2026 Bayesian meta-analysis.

Regulatory and Policy Updates

FDA Adds Kybella Warning After Serious Adverse Events With Off-Label Injections

19 Sept 2026 · Updated 01 Oct 2026

Anatomical illustration of the approved submental Kybella treatment area, off-label injection risks, and a persistent post-injection nodule.

Substance Abuse and Overdose

CDC Finds Cannabis in 1 in 5 Overdose Deaths—but Rarely as a Cause

09 Sept 2026 · Updated 01 Oct 2026

Forensic toxicology graphic showing cannabis detected in 21.0% of overdose deaths, versus 0.8% involved in death and only 9 cannabis-only deaths.

Regulatory and Policy Updates

FDA Toxicology Update: Injectafer Boxed Warning and DNP Recall

04 Sept 2026 · Updated 02 Oct 2026

Ferric carboxymaltose infusion with low-phosphate cue, weight-loss tablets and saline particulate inspection, illustrating three FDA safety actions.

Public Health Warnings and Recalls

FDA Finds Dangerously High Yohimbine Plus Hidden Tadalafil and Flibanserin in WAP Sensual Enhancement

02 Sept 2026 · Updated 01 Oct 2026

WAP Sensual Enhancement under laboratory review beside labeled evidence samples for dangerously high yohimbine, undeclared tadalafil, and undeclared flibanserin.

Public Health Warnings and Recalls

FDA Glutathione Endotoxin Investigation Expands With Greenwich Rx Recall

02 Sept 2026 · Updated 04 Oct 2026

Greenwich Rx glutathione 200 mg/mL recall highlights 10 affected lots, potential elevated endotoxin, and two ED reports after IV administration.

Public Health Warnings and Recalls

FDA Finds Hidden Sildenafil and Tadalafil in Two Sexual-Enhancement Products

16 Aug 2026 · Updated 01 Oct 2026

Two unbranded sexual-enhancement products beside sildenafil and tadalafil tablets, with a nitrate medication warning and blood-pressure monitor.

Public Health Warnings and Recalls

FDA Confirms Yimmugo C795314 Withdrawal After Safety Alert

16 Aug 2026 · Updated 16 Oct 2026

Hospital pharmacy graphic shows Yimmugo lot C795314 voluntarily withdrawn October 7 after an FDA safety alert, alongside four August withdrawn lots.
Showing 21–30 of 234
1234524